Assessment Form
Contents
1. 35 Appendix 5 SSCIF timeline otra aba ais 38 About this document 1 This document is a guide for those interested in making a Step 1 submission to the 2013 14 NHS England Specialised Services Commissioning Innovation Fund SSCIF 2 f you require general background information about the SSCIF you can find that in the following documents which are published on the NHS England website They include e About the SSCIF e SSCIF Frequently Asked Questions 3 Please see the SSCIF webpage www england nhs uk resources spec comm resources sscif for more information Background to the creation of the SSCIF Programme 4 Following the publication the Government s Plan for Growth report in March 2011 the Department of Health DH carried out a consultation exercise on how to drive up quality in the NHS through innovation Its response Innovation Health and Wealth IHW accelerating adoption and diffusion in the NHS was published in December 2011 This included a recommendation for NHS England then called the NHS Commissioning Board to create a Specialised Services Commissioning Innovation Fund SSCIF Programme Further information about the SSCIF Programme can be found at www england nhs uk resources spec comm resources sscif where you find About the SSCIF and a set of frequently asked questions About the SSCIF Programme 6 The purpose of the SSCIF Programme2. Contributors Invite user 9 Marshall R Collins test Moderator Edit role Here you can either invite a user from your organization by name autosearch or invite an external user based on his e mail address A P 4 verification mail will be sentto the user including Private team discussion a linkto this page Wie a comment Search for user i Upload file invite as moderator Add comment optional Invite You can also exit out of the browser and log back in to return to work at a later time You will be able to go back to your proposal by going to the my page tab and my initiatives below 20 e gt C la https sscif colab induct no maya companymain aspx Marshall R Collins test Logout Main Page My Page v San Groups m2 4 _ E My tasks 4 E My messages 21 Welcome to the 4 id SSCIF submission site PF settings Submit your application to the Specialised Services Commissioning Innovation Fund SSCIF Note The site is being used for testing training and validation until the submission is scheduled to open on July 15 tbs test submissions before then will be deleted on July 13th unless requested otherwise Plesse contact John Collins joollins1 1 partners org with any questions or comments about the submission site itself with questions about the SSCIF process to the NHS England team Make your submission 2D Main Page My Pag
3. Pre launch notification will take place on 2 August 2013 The SSCIF Programme will be open to submissions in the week commencing 2 September 2013 To enable applicants to prepare for submission of the Step 1 Self assessment form the website was launched on 2 August 2013 Please note that completed forms cannot be submitted until 2 September 2013 Step 1 Self assessment forms can be completed as soon as the fund is launched and this will generate a request for a Step 2 Qualifying submission form to be made available to the Lead Applicant and team he she invites into the secure web based work space The deadline for Step 2 Qualifying submission forms is midnight on 4 October CRG Chairs will be sent links to score the Step 2 submissions for their area as they are submitted with the final batch of scores needing to be submitted by midnight on 25 October Scores will be collated in order of the highest score first and shared with the Directors of the Programme of Care Boards to discuss between 29 and 31 October to agree minimum score level for Lead Applicants to be invited to submit Step 3 submissions Successful Lead Applicants will receive links to the Step 3 submission forms on 1 November for completion and uploading by midnight on 28 November including making an offer of development support from an Academic Health Science Network AHSN From 4 December the SSCIF Programme Administration Team will batch
4. Healthcare Practitioners will have completed signed and acknowledged the 38 SSCIF Evaluation Project Service Level Agreement final Project Initiation Document and Patient Access and Exit Strategy to the SSCIF Programme Administration Team 15 Around 24 February 2014 NHS England Directors will counter acknowledge each of the SSCIF Evaluation Project Service Level Agreements 16 Week commencing 25 February 2014 SSCIF evaluation projects will start 39
5. OKM PME El Main Page My Page Portfolio Groups Welcome to the NHS England SSCIF submission site Submit your application to the Specialised Services Commissioning Innovation Fund SSCIF Note The site is being used for testing training and validation until the s on July 13th unless request jcollins11 partners org with any questions or comments about the submission site itself with questions about the SSCIF process to the NHS Ecclandisan Make your submission You may begin your submission by clicking the blue button to start the process where you will be taken to the following page gl Marshall Collins test Logout LAB Ma Page Portfolio Groups Ors mo Bi Your pr se Proposal title Clinical Reference Group Choose from the list v 1 Lead Applicant First Name Last Name Organisation Email address My phone number Including area code if a landline more questions in between not shown here 23 e gt C https sscif colab induct no pages submit aspx type Proposal amp it 2094 pa O T understand that the practicing Lead Healthcare Practitioner and will be required to assemble an appropriate project team 5 with the skills and experience to deliver the service in a healthcare service setting and evaluate its impact Yes 4 3 Governance and Monitoring will be able to set out the proposed governance
6. or substantial benefits over and above existing treatments in terms of patient outcomes and or service efficiency If the innovation is a product it should have the relevant marketing authorisation or approval by a competent authority such as the CE mark which is the manufacturer s declaration that the product meets the 16 requirements of the applicable European Commission directives for medical devices and the Medicines and Healthcare Products Regulatory Agency e The quality and cost impacts in patient care that the innovation affects and the specific process steps impacted upon must be clearly defined e There is sufficient evidence of the benefits of the innovation to justify investment in an evaluation project to gather additional data through managed use in a healthcare provider setting e There is insufficient evidence at the time of submission to enable a substantive commissioning decision or to allow evaluation by bodies such as the National Institute for Health and Care Effectiveness NICE or through other highly specialised processes to support a commissioning decision independent of the SSCIF The SSCIF should not be seen as providing a second chance where commissioning decisions have already been determined e The prospect of funding from the SSCIF will significantly increase the likelihood of generating sufficient information for commissioners to make a decision about whether the innovation should be used in the NHS
7. Y Following 0 followers B8 05 07 2013 Show your appreciation Help out get access to documents andtasks Get notified when something happens This document belongs to the task E Complete Step 2 Web Submission Form Marshall R Collins test Create new web document Upload file Step 2 Qualifying Submission Revision 0 05 July 2013 8 Export this page to pdf Step 2 Qualifying Submission Eres Document overview SPECIALISED SERVICES COMMISSIONING INNOVATION FUND STEP 2 QUALIFYING SUBMISSION FORM Welcome SSCIF NOTE Each section is saved individually so you can exit after closing each section and all your work is saved Registration Page Also questions 1 2 will be prepopulated therefore this submission form starts with question 3 fm Step 1 Submit 3 If this submission is made in partnership with other organisations please list the partners including contact names email addresses and name of organisations 2000 characters maximum Required Here you may go into each section by clicking the edit button green circle to answer each question where you then click save when you are done It is important to save each section in order to assure that no work will be lost You may exit out of the window and log back in as many times as you like to complete the submission 26 After the final field is complete the following message will show up gt B https sscif colab induct no Pages IdeaPage a
8. and send completed Step 3 submissions to AHSNs for review peer review for return by midnight on 3 January On 6 January 2014 the SSCIF Programme Administration Team will identify the list of innovations across the four outcomes 1 Rejected 2 Fast track innovations list to inform future commissioning decisions 3 A shortlist of potentially quality improving and cost effective solutions with a recommendation for funding and 4 Innovations with a recommendation for a face to face meeting with the Step 4 Fund Decision Panel 10 On 9 January 2014 Lead Applicants and Lead Healthcare Practitioners to be invited to meet the Step 4 Fund Decision Panel which will take place on 21 January 11 The SSCIF Programme Step 4 Fund Decision Panel Day will take place on 21 January 2014 and any conditional offers will be made the following day 12 On 22 January SSCIF Programme Administration Team invites AHSNs to undertake Post Offer Due Diligence for the submissions which have been made a conditional offer This work takes place between 22 January and midnight on 19 February 2014 13 On 27 January 2014 the SSCIF Programme Administration Team will share with Lead Applicants the SSCIF Evaluation Project Service Level Agreement template to complete Schedule 1 and so that they can start to prepare the Project Initiation Document and Patient Access and Exit Strategy 14 Between 27January 2014 and 20 February Lead Applicants and Lead
9. innovations that fall within the direct specialised commissioning responsibilities of NHS England or are applied in a novel way to these prescribed services and e innovations that have shown promise of delivering an improvement in the quality or cost of service delivery Funding Available 25 There is up to 50 million available as a non recurrent fund for SSCIF evaluation projects in 2013 14 This cost is to cover the evaluation and administration costs for the fund and all project costs to be incurred in 2014 15 and 2015 16 for the projects approved in this first round of the SSCIF Programme 26 Baseline service costs relating to the pathway of care or treatment programme to which the innovation is being applied will not be met by the SSCIF as these are covered by existing NHS England contracts Similarly overheads for NHS Trusts or NHS Foundation Trusts cannot be included in the evaluation costs as these are already funded via existing NHS funding arrangements The SSCIF will therefore only fund genuinely additional treatment costs associated with the innovation and evaluation costs 27 Partners to submissions may be able to part fund submissions 28 Arange of submissions for small or larger amounts of funding are welcomed with the smaller amounts starting from 5 000 and the higher end up to a maximum of 25 of the fund value 29 Where partnership submissions are received and the partners are non NHS organisations with acc
10. is to support evaluation projects linked to innovations which are already in the adoption phase of the innovation pipeline not those in the earlier invention or later diffusion phases There are other funds and support mechanisms to support innovators and invention at these points Shown below in Figure 1 are the four steps in the adoption section of the End to End Innovation Pipeline that the SSCIF Programme will fund These are effectiveness evaluation effectiveness testing innovation implementation and early implementation Figure 1 End to End Innovation Pipeline Prototype Effectiveness Evaluation ME Effectrveness Testing Adoption Innovation Implementation Early Implementation Diffusion 10 The SSCIF Programme will fund projects to generate new information evidence and data on the impact of innovations including improvements in quality and outcomes for patients and service users and or efficiency or reduced NHS activity levels SSCIF evaluation projects will be rapid typically between six to 18 months in duration The services that will be covered are the 143 prescribed specialised services directly commissioned by NHS England These services are commissioned on a national basis by NHS England using single national service specifications to set out exactly what is required from service providers in terms of standards and quality of patient care The commissioning of these services is clinically led th
11. member Following 0 followers 05 07 2013 Show your appreciation Help out get access to documents and tasks Get notified when something happens Step 2 Form Ready for Review Create new web document Upload file Step 2 Qualifying Submission Revision 0 05 July 2013 8 Exportthis page to pdf Step 2 Qualifying Submission Document overview Welcome SSCIF SPECIALISED SERVICES COMMISSIONING INNOVATION FUND STEP 2 QUALIFYING SUBMISSION FORM NOTE Each section is saved individually so you can exit after closing each section and all your work is saved Registration Page Also questions 1 2 will be prepopulated therefore this submission form starts with question 3 Com Step 1 Submit 3 If this submission is made in partnership with other organisations please list the partners including contact names email addresses and name of organisations 2000 characters maximum From here you can still go in and edit each question and log out as many times as you like When the wiki is complete you may click the blue Step 2 Form Ready to Review button green circle which will then officially submit the proposal for step 2 review The process will be repeated for step 3 and so forth 27 Appendix 3 Guide to completing the Step 1 Self assessment form On this side are the questions from the Step 1 Self assessment form On this side is the explanation behind the question and what to consider when answering it 1 Lead Applicant G
12. would be a second diagram showing the place at which the innovation is used and a description of the difference it would make in terms of quality or efficiency such as shown in the text box below Innovation used at this point Impact is to reduce bed days from 8 to 5 35 Picture 1 Renal Transplant Care Pathway Potential suitability Dialysis for kidney Conservative transplant management Medical work up for kidney transplant Work up of potential living donor if available Surgical work up for kidney transplant Maintenance on list Kidney Transplant Follow up in Transplant unit Live donor nephrectomy Follow up in Specialist Renal Centre Reproduced with permission from Keith Rigg Chair Renal Transplant Clinical Reference Group and Consultant Surgeon 36 Picture 2 Renal Transplant Care Pathway spilt by key sections of the pathway Potential suitability for kidney transplant Dialysis Conservative management ent Medical work up for kidney transplant Work up of potential living donor i Suitability and MDT page r review d transplant Follow up in Transplant unit Follow up in Transplant Unit failed gt Specialist Renal Centre Reproduced with permission from Keith Rigg Chair Renal Transplant Clinical Reference Group and Consultant Surgeon 37 Appendix 5 SSCIF timeline
13. England THE NHS CONSTITUTION NHS England INFORMATION READER BOX Directorate Medical Operations Patients and Information Nursing Policy Commissioning Development Finance Human Resources Publications Gateway Reference Document Purpose Guidance Document Name SSCIF Step 1 User Guide Author NHS England Publication Date 08 August 2013 Target Audience CCG Clinical Leaders CCG Chief Officers Managing Directors Care Trust CEs Foundation Trust CEs Medical Directors Directors of PH Directors of Nursing NHS England Regional Directors NHS England Area Directors NHS Trust Board Chairs Special HA CEs Directors of HR Directors of Finance Allied Health Professionals GPs Communications Leads Emergency Care Leads Directors of Children s Services NHS Trust CEs industry non nhs providers Additional Circulation List Description Things to consider when preparing to answer the SSCIF Step 1 Self Assessment Form Cross Reference Superseded Docs if applicable Action Required Reference material for making submision to the SSCIF Timing Deadlines if applicable Contact Details for Bernie Stocks further information Specialised Services Team Fosse House Leicester LE19 1SX For immediate publication Document Status This is a controlled document Whilst this document may be printed the electronic version posted on the intranet is the controlled copy Any printed copies of this docum
14. Programme if it is already on the market and have the relevant marketing authorisation or approval by a competent authority such as the CE mark which is the manufacturer s declaration that the product meets the requirements of the applicable European Commission directives for medical devices You will need to provide evidence of this at Step 2 31 3 10 3 11 Delivery understand that will need to identify a practising Lead Healthcare Practitioner LHP to act as sponsor the SSCIF evaluation project and lead the project involving the use of the innovation for its duration and the parallel evaluation of the impact of the innovation Yes No The team can include support and input from staff from partner organisations understand that the practising Lead Healthcare Practitioner and will be required to assemble an appropriate project team with the skills and experience to undertake the project in a healthcare service setting and evaluate its impact Yes No The team can include support and input from staff from partner organisations The SSCIF is to fund projects in a healthcare setting using an innovation or innovative approach This process will require appropriate clinical leadership from a clinician what we refer to as the LHP role who is currently practising and has the relevant authorisation to do so including nurses allied health practitioners such as occupational therapists clinical scientist
15. Specialised Ophthalmology Services OPS D13 Spinal Cord Injury SCI D14 Complex Spinal Surgery CSS D15 Major Trauma MTS D16 Adult Critical Care ACC Programme of Care Women and Children E1 Medical Genetics MGS E2 Paediatric Surgery PSS E3 Paediatric Medicine PMS E4 Paediatric Cancer Services PCS E5 Congenital Heart Services Paediatric Cardiac Services PCA E6 Metabolic disorders IMD E7 Paediatric Intensive Care PIC E8 Neonatal Critical Care NIC E9 Paediatric Neurosciences PNS E10 Complex Gynaecological Services CGS E11 Specialised Maternity Services SMS 20 E12 Fetal Medicine FMS E13 Multi System Disorder MSD 21 Appendix 2 Using the SSCIF to CIMIT CoLab Web Platform Please follow the instructions below to e Create an account e Make your Step 1 Self Assessment submission e Save your submission e Submit your submission Login Page 56 e G hitps sscif colab induct no login 1 National Health Service E mail your Induct ID AAA E If you already registered in the system you may do so here if you need to register click on the create an account link where you can provide your name and email to gain access Main Page After logging in you will be brought to the SSCIF main page below 22 gt 8 nttps sscit colabinductno maya companymainaspr Marshall R Collins test Logout
16. and monitoring arrangements for the project O Yes 4 4 Partners Y If there are partners to this submission they have agreed to participate in the project and support its delivery O Yes O No O Does not apply 5 Agreement to terms and conditions 5 1 Final Decision Y accept that the views of the assessors and Fund Decision Panel are final O Yes 5 2 Inform happy for you to forward details of this submission to colleagues at NICE for information O Yes O No Please Note of the above questions must be answered with one of the available responses as requirement to pass the self assessment and move to complete the Step 2 Qualifying Submission Form After all the fields are complete you may click save which will create an online workspace for you to begin working on the step 2 submission form shown below w gt C 8 https sscif colab induct no Pages IdeaPage aspx query aplOggg4VGOfAKDxQ1IEzY IHBul2BFArFjI06013Cu 8baWBCSyNi RR InfCiLOs tabWorkspace Page MyPage Portfolio Groups test Current stage Step 2 Qualifying Submission Form Proposal SSCIF SSCIF COLAB 1147 Marshall R Collins test Owner 1 member Y Following 0 followers 13 09 09 Show your appreciation Help out get access to documents and tasks Get notified when something happens overiow This document belongs to the task El Complete Step 2 Web Submission Form Marshall R Collin
17. are pathway or relevant section of this which relates to the innovation and describe what is different between what happens now and how this will be different when the innovation is being used in the SSCIF evaluation project Please see Appendix 4 Guide to response National evaluation processes require full evidence to be provided for evaluation of the impact of an innovation and many innovations in specialised services may not have this level of data due to the 29 SSCIF evaluation project to generate data and information to bridge the evidence gap for the innovation and answer key commissioning questions which are unanswered at this time Yes No Guide This may be your view or you may have previously approached specialised services commissioners and they were concerned about the lack of data and other evidence and were unable to commission the innovation as a result small number of patients across the country with some conditions If this is the case pick yes If there is a full evidence base the innovation will not be suitable for the SSCIF choose no The SSCIF aims is to provide funding to generate the additional information needed by NHS England for commissioning decisions and whilst there will not be a full evidence base for the innovation there will be some evidence from case note audit randomised controlled trials etc 3 7 can confirm that to the best of my knowledge the collection o
18. at new area 34 Appendix 4 About the patient s care pathway 1 Acare pathway shows in picture form the patient service user s journey between the beginning and end of their journey or particular parts of this such as 1 home to General Practitioner GP 2 GP to the hospital or other care setting 3 within different parts of the hospital system such as i outpatient to ii list for surgery to theatre to iv recovery to v intensive care to vi general ward and 4 hospital to home care home other will have a number of separate steps of assessment and interaction with health staff and is known as the patient service user care pathway 2 Assessors will want to understand at what point in the patient service user s journey the innovation is used and where it impacts and the difference this will make in the number of steps in the care pathway as compared to the current situation 3 For the Step 2 Qualifying Submission Form you will need to set out the care pathway as it is currently and how this will be different using the innovation 4 Below in Pictures 1 and 2 is an example of a renal transplant pathway as it is currently this would be the current pathway and is shown in two formats one for the overall journey and a second showing how the pathway breaks down into four key elements of assessment maintenance transplant and follow up 5 lf there was an innovation in this pathway there
19. d data sets to be captured to measure the impact of the innovation and clarity as to whether this 1 already automatically collected or will need to be manually captured by the project team As the SSCIF Programme is primarily aimed at providing information for commissioners submissions will need to specify 12 the key commissioning performance indicators KPls that the innovations will impact upon to inform the commissioning decision Key Performance Indicators KPIs can include at least one of the metrics in Table 2 below and preferably a bundle of these 9 Financeand The costs of the project will be required at Step 2 and Step 3 activity with as detailed an outline of the costs at Step 2 and an excel spreadsheet to be completed at Step 3 on which the service activity is to be included 10 Intellectual Clarity as to whether any background intellectual property Property rights for the innovation are already in place and if not a clear plan for ensuring this is secured for the relevant parties All of the rights title and interest in or to any information data reports documents procedures forecasts technology Know How and any other Intellectual Property Rights whatsoever owned by either NHS England or the LHP before the commencement date of the project shall remain the property of that party 11 Public and Patient and public engagement should be a key part of the Patient design delivery and
20. e Portfolio Groups My initiatives My initiatives El My tasks 4 EA My messages 21 O Idea Proposals Es My profile My settings Only active Only archived All Initiatives follow webex testing fri Updated at 05 07 2013 Created by Marshall R Collins test webex test 2 Updated at 04 07 2013 Created by Marshall R Collins test testin Updated at 04 07 2013 Created by Marshall R Collins test 8 webex test 1 Updated at 04 07 2013 Created by Marshall R Collins test testing as std user 6 26 Updated at 26 06 2013 Created by Marshall R Collins test View more results Note make sure you click proposals to see your initiatives From here you may click on the blue title of each proposal to be taken to the workspace You may either choose to begin working on your proposal right away or log out and then log back in to your proposal to complete the online wiki Please note when you log back in you should click on the documents tab circled to view the wiki gt B hittps sscif colab induct no Pages IdeaPage aspx query VqbntCJCDDG sol0gPNOMxxaD8PXOvKB_1c2qfR98KmKbPoivDWV6 kLIMRbZdCWO tabWorkspace pd o H IMIT Marshall R Colins test Logout Main Portfolio Groups ma as webex testing fri Current stage Step 2 Qualifying Submission Form Proposal SSCIF SSCIF COLAB 1121 Marshall R Collins test Owner 1member
21. ent are not controlled As a controlled document this document should not be saved onto local or network drives but should always be accessed from the intranet Specialised Services Commissioning Innovation Fund SSCIF User Guide Completing the Step 1 Self Assessment Form First published August 2013 Prepared by Medical Directorate NHS England Contents CONTENTS isis 4 ADOUT this document RTT TT 5 Background to the creation of the SSCIF 6 About the SSCIP Programme Ran REFER VE MEI EC a IRE EE VE EP EE IAE 6 The scope of the SSCIF cocinar 9 F liding Available aa 10 Who can apply to the SSCIF nnna 10 What to be aware of in planning a submission to the SSCIF 11 What are the SSCIF Programme submission and assessment processes 15 What are the SSUIF entry criteria iii 16 jc A 17 Appendix 1 List of NHS England specialised services Clinical Reference Groups CRG by Programme of Care eee 18 Appendix 2 Using the SSCIF to CoLab Web Platform 22 Appendix 3 Guide to completing the Step 1 Self assessment form 28 Appendix 4 About the patient s care
22. ess to significant in house funding and resources it is envisaged that submissions will not include costs to pay for such support and the appropriateness of the support requested will be considered as part of the Step 3 table top assessment process Who can apply to the SSCIF Programme 30 At Step 1 and Step 2 in the three step submission process anyone can apply to the SSCIF Programme including the voluntary sector NHS Trust NHS Foundation Trust or non NHS provider staff commissioners managers and multi professional clinicians of all levels industry and independent sector providers 31 Submissions can be developed in partnership with one or more of the above organisations What to be aware of in planning a submission to the SSCIF 32 Successful SSCIF submissions at Steps 2 and 3 of the SSCIF are likely to demonstrate a clear understanding of the following areas and include plans to put these in place if the submission is successful in being awarded funding Table 1 What to be aware of in planning a submission to the SSCIF 1 Lead clinician identified in a NHS Trust NHS Foundation Trust or non NHS provider A practising Lead Healthcare Practitioner LHP to act as clinical lead The LHP will be responsible for clinical sponsorship of the submission oversight of the delivery of the service involving the use of the innovation and the parallel evaluation of the impact of the innovation 2 Executive Direct
23. evaluation of the impact of the innovation Engagement on outcomes and the patient service user s experience of the care journey This should be evidenced 12 Freedom of The Freedom of Information Act gives the right to the general Information public interested parties to ask public authorities for information they hold in relation to a specific issue NHS England will comply fully with the obligations placed upon it by the Freedom of Information Act FOIA and to ensure that the service it provides for those wishing to gain access to information is simple efficient and effective Any queries relating to the Specialised Services Commissioning Innovation Fund will be managed by the NHS England FOIA team at Tel 0300 3 11 22 33 Email england contactus nhs net Address NHS England PO Box 16738 Redditch B97 9PT Lead Applicants of submissions will need to make themselves familiar with the Freedom of Information Act accessed via the Information Commissioner s website www ico gov uk to view the basis for any exemptions they feel apply to any requests for information from the public under the FOIA 13 Equality and Diversity Equality and diversity are at the heart of the NHS strategy Due regard to eliminate discrimination harassment and victimisation to advance equality of opportunity and to foster good relations between people who share a relevant protected characteristic as cited in under the Equa
24. f data to support the commissioning of this innovation is not better suited to being collected in a more formal research and development setting Yes No Guide A SSCIF evaluation project would generate data to inform a commissioning decision More formal research and development evaluations may have already been completed for marketing authorisation but formal testing in an NHS service setting may be required to generate additional peripheral information that cannot be generated in a clinical trial setting This is asking for confirmation that the work needed is not a research project Research is about testing whether something works and developing a final concept whereas the SSCIF is about taking something that is already proven and testing out whether it works in a different setting for a different clinical indication across a larger patient population or in a clinical setting for the first time You are advised to discuss this with an appropriately qualified person such as your organisation s research 30 The SSCIF Programme is designed to assess the value of an innovation to the NHS and not to answer early stage research questions Innovations are therefore to have reached a level of evidence to enable use within the NHS outside of a research setting department local Academic Health Science Network AHSN NHS Innovation Hub or relevant specialised services area team 3 8 Evidence You will be asked t
25. inned by timely and accurate data on activity and outcomes so that there 1 a clear picture of progress which can be reviewed by the Executive Sponsor and the project team An understanding of the patient service user s journey A clear picture of the patient s journey currently particularly the flow from GP referral to care and back home and how it will be improved or different as a result of using the innovation Clarity about how many patients can realistically be included in the service to be provided as part of the project during the timeframe it covers across the single or multiple provider units covered by the project Clarity about how many patients will benefit during the project for the population to be covered and how many would benefit nationally if the use of the innovation was rolled out across all appropriate providers The potential benefits of the innovation A clear understanding of the promise and benefits of the innovation over what is currently in use in the NHS underpinned by supporting data and evidence The right skills and experience in the project team Data Recruitment plan for an experienced project team which will have all of the necessary skills to agree actions including service delivery evaluating the impact of the innovation on the service and the patient service user ensuring appropriate data collection and production of monitoring reports Clarity of the key data an
26. lier of a service or a participate in the project and support its delivery Yes No Does not number of provider trusts collaborating on the project apply submission they are fully signed up to being involved in using the innovation in their unit for the duration of This may include contributions from a number of partners the project carrying out data collection and putting in place all of the elements of the project in a rigorous manner Evidence of this and the support of their Chief Executives Medical or Nursing Directors and Directors of Finance will be required in Step 2 4 Agreement to te 218 Mojo plo 1010 aqe tO response 4 1 accept that the decisions of the various assessors and Fund In making a submission to the SSCIF Programme you Decision Panel are final Yes No accept the views of the various assessors which will be called upon to give opinion on the submissions which may result in your innovation being funded or not funded 4 2 Information about technologies referred to in this submission may This question will not affect the decision to proceed to be shared with the National Institute for Health and Care Excellence NICE Yes No Does not apply step 2 of the process At both Steps 1 and 2 of the SSCIF submission process where the innovation is a 33 Please note that if you give your permission and your innovation is a device medicinal product or technology we will forward basic informa
27. lity Act 2010 and those who do not share it has been given throughout the development of the policies and processes cited in this document Applicants to the SSCIF Programme will be asked to have due regard and give robust consideration to equality in the development and implementation of their innovation submissions and in their projects if awarded funding ensuring that people with protected characteristics or those that find it hard to access services which are provided in a traditional way are not discriminated against Those administering the SSCIF will also need to have due regard to equality in the assessment and prioritisation processes In addition assessments will include both the potential cost effectiveness of innovations and their potential impact on reducing health inequalities in access to and outcomes from health services Table 2 SSCIF project metrics Key Performance Indicator Description Quality of care Appropriate to the service area Outcomes of care Appropriate to the service area Activity Length of stay admissions readmission rates accident and emergency admission rates emergency admission rates Cost Impact on running costs such as in number of cases revenue or capital costs Patient Reported Outcome Family and Friends test Measures PROMS qualitative comments and surveys specialty specific evaluation measures 14 What are the SSCIF Programme
28. nd Blood B1 Radiotherapy RTY B2 PET CT PET B3 Specialised Cancer SCR B4 Blood amp Marrow Transplantation BMT B5 Haemophilia and other bleeding disorders HPA B6 HIV HIV B7 Infectious Diseases INF B8 Haemoglobinopathies HAS B9 Specialised Immunology and Allergy Services IMM B10 Thoracic Surgery TSY B11 Upper Gl Surgery UGI B12 Sarcoma SCA B13 CNS Tumours CNS B14 Specialised Urology URO B15 Chemotherapy CTY B16 Complex Head amp Neck HAN B17 Teenage and Young Cancer TYA Programme of Care Mental Health C1 Specialised Services for Eating Disorders EDS C2 High and Medium Secure Mental Health HSM C3 Low Secure Mental Health LSM C4 Specialised Mental Health Services for the Deaf MSD C5 Gender Identity Services GIS C6 Perinatal Mental Health PMH C7 Tier 4 Child amp Adolescent Mental Health Services CAM C8 Tier 4 Severe Personality Disorder Services adults SPD C9 Mental Health Specialised MHS C10 Forensic Pathway Group FSG C11 CAMHS Secure CSM Programme of Care Trauma D1 Complex Disability Equipment CDE 19 D2 Brain Injury amp Complex Rehabilitation BIR D3 Adult Neurosurgery NSY D4 Neurosciences NSC D5 Stereotactic Radiosurgery SRS D6 Burn Care BCS D7 Cleft Lip amp Palate CLP D8 Specialised Pain SPS D9 Specialised Ear Surgery SES 010 Specialised Orthopaedic Services SOS D11 Hyperbaric Oxygen Therapy HBO D12
29. o provide a summary data and have undertaken a thorough literature review and structured information resulting from a thorough review of the search of the current information about the performance of the current published literature setting out the clinical case innovation and can provide that on request Yes No for the need that the innovation addresses Guide This can either be unpublished data such as local registry The data will need to be clinically and statistically data patient record data or as published in journals We advise significant and be from published or un published that you do not submit a proposal until you have gathered the sources that will need to be appropriately referenced information you will need to answer this question We accept that such as using the Cochrane system the evidence base may be limited as there must be an evidence gap that needs to be filled to qualify for the SSCIF Programme but This will need to be included at Steps 2 and 3 in the all supporting data will be required by assessors SSCIF submission process 3 9 confirm that appropriate approval is in place for this innovation if If the innovation is a product or a device it will only be the innovation is a medicinal product or device such CE marking for a medical device or marketing authorisation for a drug Yes No Does not apply Please note that this question does not apply to pathways and workforce approaches suitable for the SSCIF
30. ocess as a result of this innovation being used or applied In my view there is insufficient evidence at this time to enable specialised services commissioners to commission the innovation or to take this innovation through national evaluation processes which require a complete evidence base It therefore warrants a 3 2 Which of the following specialised services Clinical Reference See the list at Appendix 1 The innovation must fit into Groups CRGs does the innovation best fit see list of 74 NHS at least one of these service areas It may cross a England specialised services CRGs number but choose the single best fit 3 3 Will this innovation impact on the pathway for adults children both If the innovation is common to adult and paediatric tick one pathways tick both if not tick whichever applies 3 4 The innovation is distinctly different from the range of approaches This is asking for confirmation that you believe the used throughout the country and offers improved patient outcomes innovation is significantly better than what is already and quality or service efficiency Yes No being used have some evidence to support this and will be able to set out the differences in later steps Guide Is it radically different to other current approaches or solutions If so could you describe how later on in the process 3 5 have identified the steps in the patient care pathway that this At Step 2 you will be asked to set out the c
31. ocesses cited in this document 21 Applicants are asked to give due regard and robust consideration to equality in the development and implementation of their innovation submissions and in their projects if awarded funding ensuring that people with protected characteristics or those that find it hard to access services which are provided in a traditional way are not discriminated against 22 The SSCIF Programme supports the delivery of the NHS Outcomes Framework 2013 14 in those circumstances where a SSCIF evaluation project which secures investment sits within one of the five domains which focus on improving health and reducing health inequalities Domain 1 Preventing people from dying prematurely Domain 2 Enhancing quality of life for people with long term conditions Domain 3 Helping people to recover from episodes of ill health or following injury Domain 4 Ensuring that people have a positive experience of care Domain 5 Treating and caring for people in a safe environment and protecting them from avoidable harm The scope of the SSCIF 23 The scope of innovations that will be considered by the SSCIF Programme is broad including innovative service models pathways workforce and team approaches technologies products medicines interventions devices and diagnostics with the potential to deliver high impact changes in prescribed specialised services directly commissioned by NHS England 24 The SSCIF Programme is for e
32. or Sponsorship Identified Executive Director leads in each partner organisation This will be somebody who will drive the delivery of the projects negotiating any potential hurdles should they arise They will approve the proposed submission to ensure compliance with organisational costing and approvals processes before the submission is made In an NHS organisation this will ideally be the Chief Executive or Medical Director or Director of Nursing or Director of Finance Accounting Officer In a non NHS organisation this role will be that of the Managing Director Approval will be needed from the Executive Director lead in the case of a conditional offer being made by the Step 4 Fund Decision Panel The Executive Director lead will be responsible for approving the Service Level Agreement that will be included 11 in the SSCIF Standard Operating Procedure thereby adhering to the terms and conditions of the SSCIF Programme Support from operational level experts in the provider trust s Support from business managers plus the finance and information team in the LHP s organisation will be required to ensure the accuracy of the finances and service activity information to be included in the submission at Steps 2 and 3 and that the accuracy of these is agreed and authorised internally before the submission is made Governance Clear governance processes supporting the running of the project underp
33. organisation will be responsible for the delivery of the SSCIF evaluation project and for ensuring oversight of service delivery and financial management of the project on an operational basis This organisation will be known as the Applicant Organisation It is expected that patients service users and carers will be engaged in the development delivery and evaluation of submissions to the SSCIF and in SSCIF evaluation projects to ensure that there is an understanding of the innovation s impact on the patient s experience and to enable feedback on ensuring an optimum care experience Where information resulting from a research study or similar activity is submitted in support of an application to the SSCIF the study must have been approved and conducted in accordance with formally established research governance arrangements This would also apply to information used in the adoption phase should the application be successful Confirmation of research ethics approvals must accompany the application Data that could identify a patient either directly or indirectly must not be submitted Equality and Diversity 20 Due regard to eliminate discrimination harassment and victimisation to advance equality of opportunity and to foster good relations between people who share a relevant protected characteristic as cited in under the Equality Act 2010 and those who do not share it has been given throughout the development of the policies and pr
34. rough a system of Programmes of Care and Clinical Reference Groups CRGs The contracting of services is led at a local level by 10 of the 27 NHS 11 12 13 14 15 16 17 18 19 England area teams For further information about the prescribed services please go to www england nhs uk resources spec comm resources npc crg The outcomes of the evaluation projects will be used by NHS England commissioners to make more informed commissioning decisions resulting in new commissioning policies or service specifications There is likely to be more interest in the fund than resources available therefore any submissions which include funds from partners and or other organisations will enable the SSCIF Programme monies to be allocated across more projects No preference will be given to submissions with matched funding The decision of the assessors is final No undue pressure or influence is to be exerted on assessors or the SSCIF Programme Administration Team The person who completes the Step 1 Self Assessment Form will be known as the Lead Applicant and will be the main point of contact throughout the submission process There is a requirement to identify a practising clinician who will be known as the Lead Healthcare Practitioner LHP who will sponsor the submission lead the delivery of the project including service delivery as well as the evaluation of the impact of the innovation The practising LHP s
35. s pharmacists medical staff etc The LHP role is similar to the Principal Investigator role in research activities Where more than one provider organisation is collaborating on a project for example three NHS Trusts then there will be a single overall LHP who will co ordinate the project delivery data collection and clinical standards with individual clinical leads at each provider site The project team will need to include a diverse range of skills competencies and experience covering the clinical elements and project management activities although it is expected recommended that additional support is secured from provider teams such as innovation research evaluation information finance governance service management supplies equipment testing if appropriate 32 3 12 will be able to set out the proposed governance and monitoring arrangements for the project Yes No This may include contributions from a number of partners Robust project set up will be expected and Lead Applicants will need to set out their plans for this in Step 2 and 3 This would need to include identification of the senior responsible owner such as an executive director to steer the delivery of the project and hold the team to account for delivery a project manager and regular reporting and steering group meetings 3 13 If there are partners to this submission they have agreed to If there is a manufacturer or supp
36. s test Create new web document Upload file Step 2 Qualifying Submission Revision 0 11 July 2013 Exportthis page to pdf vi Step 2 Qualifying a Submission Step 1 Submit v Document overview a SPECIALISED SERVICES COMMISSIONING INNOVATION FUND STEP 2 QUALIFYING SUBMISSION FORM NOTE Each section is saved individually so you can exit after closing each section and all your work is saved Also questions 1 2 will be prepopulated therefore this submission form starts with question 3 3 Partnerships 3 1 If this submission is made in partnership with other organisations please list the partners including contact names email addresses and name of organisations Indicate None if no other partners are involved 2000 characters maximum Required tine Heerif_enlah indict nn Dane A Cs IDEA DICA E There is also the ability to add team members to the proposal red circle by entering their email in the invite user section after you click on that tab 24 gt 8 https sscif colab induct no Pages IdeaPage aspx query aplOggg4VGOfAKDxQ1IEzY IHBUI2BFArFjIO6013Cu 8baWBCSyNi RR InfCiLOs tabTeam o Marshall R Main Page Page Portfolio Groups test Current stage Step 2 Qualifying Submission Form Proposal SSCIF SSCIF COLAB 1147 Marshall R Collins test Y Following 0 followers 13 09 09 Show your appreciation Get notified when something happens
37. spx query VqbntCJCDDG sol0gPNOMxxaD8PXOvKB_1c2qfR98KmKbPoivDWV6 kLIMRbZdCWO tabWorkspace 1 o z 8 Freedom of Information Act 8 1 include here 300 words for the lay domain to be used if the submission inno Document complete innovation 3000 characters maximum Do you want to mark the task as finished E Complete Step 2 Web Submission Form Yes mark this as finished No will continue to edit 8 2 If Freedom of Information Requests 5 Administration Team will ask if have any grounds upon which some all of this information contained in this submission should not be released please respond yes ieee 9 Optional Responses to SSCIF Programme team comments Optional Response to SSCIF Programme Comments Editable in stage QUALIFYING REVIEW For ease of use you may select yes mark this as finished This will not submit the proposal yet you will still have time to change your answers After this is complete you will see the following message at the top of the page red circle gt BG https sscif colab induct no Pages IdeaPage aspx query VqbntCJCDDG sol0qgPNOMxxaD8PXOvKB_1c2qfR98KmKbPoivDWV6 kUMRbZdCW0 tabWorkspace Did o Marshall Collins test Logout Main Page Portfolio Groups webex testing fri Current stage Step 2 Qualifying Submission Form Proposal SSCIF SSCIF COLAB 1121 Marshall R Collins test Owner 1
38. submission and assessment processes 33 There are four steps in the submission process e Step 1 Self assessment form e Step 2 Qualifying submission form e Step 3 Detailed submission form e Face to face meeting with the Step 4 Fund Decision Panel 34 This document addresses Step 1 of the process only Table 3 Guide to Step 1 submission and assessment process Step 1 Making a submission Step 1 Submission and assessment process The Step 1 Self Assessment Form is a one page online checklist to be completed by the Lead Applicant to confirm that their innovation fits within the specialised services commissioning portfolio that there is enough information to answer the questions in the next steps of the submission process and that the innovation relates to a specialised service and meets the SSCIF Programme entry criteria In order to access the online self assessment form go to www england nhs uk resources spec comm resources sscif where you will find a second link to the CoLab web platform where you can register to be a user on the system The Step 1 form can be located once you have completed registration If the Lead Applicant is able to answer yes to all of the questions in Step 1 the online system will indicate that their submission has been successful and will indicate this to the SSCIF Programme Administration Team who will send the Lead Applicant an email with information about the nex
39. t step including the submission forms to complete If the Lead Applicant is not able to answer yes to all of the questions on the on line Step 1 Self assessment form the submission will automatically be rejected by the online system If this happens the innovator may wish to contact their organisation s lead Director with responsibility for innovation who may be able to advise on those issues that need to be addressed 15 in order to complete a successful submission Alternatively it may be that completing the self assessment form will demonstrate to the Lead Applicant that the innovation 1 not suitable for consideration or investment by the SSCIF Programme and other sources of support should be explored Figure 2 SSCIF Programme Submission Process for Lead Applicants Innovator develops idea design and tests Completes simple self assessment and qualifying submission Managed application process provides support Detailed submission for Panel review to inform funding decision What are the SSCIF entry criteria 35 The SSCIF Programme entry criteria are as follows The target service or patient group should be within the list of those prescribed as falling within the direct specialised commissioning responsibilities of NHS England It is recognised that some innovations may go on to have wider use across the NHS Innovations should offer the promise of either addressing an unmet clinical need
40. tion product name intended use about the technology to relevant programmes at the National Institute for Health and Care Excellence NICE For submissions for pharmaceutical innovations it is expected that the NICE Technology Appraisals Programme will already be aware of the innovation via the NICE Topic Selection function but we are happy to share this submission with them if you wish For the NICE Medical Technologies Evaluation Programme the purposes of sharing this information is to enable informal confidential and without obligation engagement between NICE and the manufacturer depending on the suitability of the product for evaluation medical technology Lead Applicants will be invited to give permission for the SSCIF Programme to share details of the submission with the NICE Medical Technologies Evaluation Programme to enable informal confidential and without obligation engagement between NICE and the manufacturer dependent on the specific innovation Where a Step 2 Qualifying Submission is made to the SSCIF and there is judged to already be a full evidence base for an innovation the SSCIF Programme Team will recommend to innovators to put forward their innovation to NICE for consideration If an innovation has already been through guidance and been recommended by NICE the product may be appropriate for use in other clinical populations or for other indications and it may be that the fund can assess its impact in th
41. uide to response Name Prefix Jones First Name Mrs Organisation Jane Email address Anywhere University Hospitals NHS Trust Confirm Email address Your own My phone number including area code if a landline Your own Questions with a star need to be answered to enable the submission to be automatically accepted Your own 2 Title of proposed SSCIF evaluation project Guide to response The title of this specialised services innovation project proposal is Please give a short title that will make it clear to all Max 250 characters readers what the innovation is about For example The Study of using the X Care Pathway approach in Paediatric Medicine for children with Y condition 3 Proposal The Innovation the Evidence and Delivery Guide to response 3 1 The Innovation Can you describe the clinical patient outcomes gap that have identified the health service problem or need or the this innovation fills or by how much it is significantly efficiency improvement that this innovation addresses Yes No more cost effective than what is used 28 3 6 innovation will impact upon and whether the impacts are to improve patient outcomes increase or reduce cost or reduce NHS activity levels e g reduce acute bed days from eight to five Yes No Guide can clearly set out the possible changes the innovation may result in to those process steps e remove three steps from a current 10 step pr
42. which would be unlikely with the current lack of evidence e There is sufficient likelihood that the innovation could be diffused through the NHS at a cost proportional to its benefit if the results from the evaluation project were successful e Providers have determined a robust mechanism to ensure that any additional costs associated with the innovation can be charged to other commissioners funders where the responsibility for an individual patient does not sit with NHS England Contact us Contact details for the SSCIF Programme Administration Team are as follows england sscif nhs net 17 Appendix 1 List of NHS England specialised services Clinical Reference Groups CRG by Programme of Care CRG ID CRG Name CRG Code Programme of Care Internal Medicine 1 Cystic Fibrosis CFS A2 Hepatobiliary and Pancreas HPB A3 Specialised Endocrinology EDO 4 Vascular Disease VAS A5 Severe and Complex Obesity MOS Renal Dialysis RDI A7 Renal Transplant RTR A8 Specialised Colorectal Services SCS A9 Complex Invasive Cardiology CIC A10 Cardiac Surgery CSY A11 Pulmonary Hypertension PHN A12 Specialised Dermatology DMT A13 Specialised Rheumatology RHU A14 Specialised Respiratory HSP A15 Interventional Radiology IRY A16 Specialised Imaging SIG A17 Specialised Diabetes SDM A18 Heart amp Lung Transplantation HLT Programme of Care Cancer a
Download Pdf Manuals
Related Search